Find a Tender
complete
Official procurement procedure
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published18 Dec 2025, 11:34 GMT | Last source update18 Dec 2025, 11:34 GMT | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-05838e | ||
What is being bought
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/25/5732
Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
What changed
From the official release history
- Official notice release published
18 Dec 2025, 11:34 GMT - tender value changed
28 Nov 2025, 12:41 GMT - Status changed to complete
28 Nov 2025, 12:41 GMT - Official notice release published
28 Nov 2025, 12:41 GMT - Submission deadline changed to published date
28 Nov 2025, 12:41 GMT - Status changed to active
19 Sept 2025, 09:52 BST - Official notice release published
19 Sept 2025, 09:52 BST - Submission deadline changed to 22 Oct 2025, 13:00 BST
19 Sept 2025, 09:52 BST - Published value updated to £176,000,000
7 Aug 2025, 15:21 BST - Status changed to planning
7 Aug 2025, 15:21 BST - Official notice release published
7 Aug 2025, 15:21 BST - Buyer information updated
7 Aug 2025, 15:21 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
18 Dec 2025, 11:34 GMT - Award active
Not published · Not published - Contract active
Signed 11 Dec 2025, 00:00 GMT · £321,349,256
Commercial outcome and competition
Awards AVENTIS PHARMA LIMITED t-a Sanofi, Northumbria Pharma Limited, PFIZER LIMITED, ROVI BIOTECH LIMITED, Techdow Pharma England Ltd, VENIPHARM LTD, VIATRIS UK HEALTHCARE LIMITED Not published · Not published · active |
Contracts CM/PHR/25/5732 - Low Molecular Weight Heparins and Fondaparinux Products £321,349,256 · signed 11 Dec 2025, 00:00 GMT · active Contract period: 1 Mar 2026, 00:00 GMT — 29 Feb 2028, 23:59 GMT |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published